[Fulminant Neisseria meningitidis B revealing multiple myeloma]
Nicolas Paleiron1, Vin BaNguyen, Diane Commandeur
1Service de pneumologie, HIA Clermont Tonnerre, Brest.
Insights
A 64-year-old woman developed purpura fulminans from meningococcal B infection, revealing an underlying multiple myeloma. This case highlights infection risks in hematologic diseases and the need for preventive strategies.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Background:
- Multiple myeloma is a hematologic malignancy associated with impaired immune function.
- Invasive meningococcal infections, particularly serogroup B, can cause severe morbidity and mortality.
- Immunosuppression in multiple myeloma patients increases susceptibility to opportunistic infections.
Observation:
- A 64-year-old woman presented with purpura fulminans, a rapidly progressive thrombotic disorder.
- The patient was diagnosed with invasive meningococcal B infection.
- Subsequent investigations revealed an underlying diagnosis of multiple myeloma.
Findings:
- The co-occurrence of purpura fulminans and invasive meningococcal B infection in a patient with multiple myeloma.
- Demonstration of severe immunosuppression secondary to multiple myeloma.
- The critical role of prophylactic measures in immunocompromised patients.
Implications:
- Highlights the increased risk of severe infections, including meningococcal disease, in multiple myeloma patients.
- Underscores the importance of early diagnosis and management of infections in immunocompromised individuals.
- Emphasizes the necessity of implementing robust prophylactic strategies, such as vaccination and antibiotic prophylaxis, in patients with hematologic malignancies.
Abstract:
We report the case of a 64 years-old woman, presenting in our hospital with purpura fulminans due to invasive meningococcal B infection. Biological exams led to the diagnosis of multiple myeloma. This case illustrates the importance of immunosuppression in this hematologic disease and allows us to insist on the prophylactic measures to be implemented.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Encephalitis l: Introduction
Multiple Sclerosis l: Introduction
